Human monoclonal antibodies to O8E
US9988453B2 · kind B2 · utility
1Cited by
35References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2016 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Feb 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to O8E with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.